Editorial: Cardiorenal dysregulation in endocrine disorders: innovative mechanisms and therapeutic interventions

Frontiers in Pharmacology

Pharmacology

Abdel A. Abdel-Rahman¹  Eman Soliman²  Noha M. Shawky³  Samar Rezq⁴ 

[1]Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States

[2]Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt

[3]Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, VA, United States

[4]Department of Pharmacology and Toxicology, Mississippi Center of Excellence in Perinatal Research, Women’s Health Research Center, Cardiovascular Renal Research Center, University of Mississippi Medical Center, Jackson, MS, United States

[5]Department of Pharmacology and Toxicology, Mississippi Center of Excellence in Perinatal Research, Women’s Health Research Center, Cardiovascular Renal Research Center, University of Mississippi Medical Center, Jackson, MS, United States

[6]Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt

关键词: cardiovascular;    renal;    endocrine;    non-coding RNA;    autophagy;   

DOI  :  10.3389/fphar.2023.1275919

 received in 2023-08-10, accepted in 2023-08-21,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Shawky, Soliman, Abdel-Rahman and Rezq.